Market
  • Company Info.

    Cohance Lifesciences Ltd.

    Live Quotes



    Registered Address
    Registered Office : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC,
    Mumbai, Maharashtra - 400093
    Tel: 022-61539999, 23549414, 23541142
    Fax: 022-23541152
    Email : info@suvenpharm.com
    Website : www.suvenpharm.com

    Key Officials
    NameDesignation
    Mr. K Hanumantha RaoCo. Secretary & Compl. Officer
    Mr. Himanshu AgarwalChief Financial Officer
    Dr. Sudhir Kumar SinghChief Executive Officer

    Listings
    BSE , BSE , NSE  

    Corporate News

    Board Meetings
    Date Purpose
    16/05/2025 Audited Results
    27/03/2025 Others
    28/01/2025 Quarterly Results

    Share Holding Pattern as on 31/03/2025
    Major Holder No. of Shares Percentage(%)
    Promoters 11,242,169 55.59
    Institutional Investors 0 0.00
    Other Investors 3,517,414 17.39
    General Public 5,462,417 27.01

    Registrar Details
    KFIN Technologies Pvt. Ltd.
    Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
    Hyderabad,500032,Telangana
    Tel : 040-67161500
    Fax : 23420814

    Today's Market

    Market Performance
    Exchange BSE
    Last Traded Price ( ` ) 24.16
    Last Traded Date 21/05/2025
    Last Traded Time -
    Change (%) -13.68%
    Day's Open ( ` ) 28.26
    Previous Close ( ` ) 27.99
    Day's High ( ` ) 29.00
    Day's Low ( ` ) 24.10
    Total Traded Qty 12617
    Value ( ` In Lacs) 3.16
    Bid Price ( ` ) 0.00
    Bid Quantity 0
    Offer Price ( ` ) 0
    Offer Quantity 0
    Exchange Code 530139
    Exchange Group X
  • Cohance Lifesciences Ltd.

    Company Profile



    Market Cap.(`) 27370.82 Cr. P/BV 13.84 Book Value (`) 77.71
    52 Week High/Low ( ` ) 1360/598 FV/ML 1/1 P/E(X) 91.15
    Book Closure 09/08/2024 EPS (`) 11.80 Div Yield (%) 0.00
    Registered Office
    Registered Office : 215 Atrium, C Wing, 8th Floor, 819-821, Andheri Kurla Road, Chakala, Andheri East, Chakala MIDC,,
    Mumbai, Maharashtra - 400093
    Tel: 022-61539999, 23549414, 23541142,Fax: 022-23541152
    Website :www.suvenpharm.com
    Email :info@suvenpharm.com
    Registrar & Share Transfer Agent
    KFIN Technologies Pvt. Ltd.
    Selenium Tower B, Plot No. 31-32,, Gachibowli, Financial District, Nanakramguda,Serilingampally Man, , Hyderabad - 500032, Telangana
    Tel : 040-67161500, 67162222    Fax : 23420814
    Other Details
    Business Group Not Applicable
    BSE Code 543064
    NSE Code COHANCEEQ
    Listings BSE , BSE , NSE
    ISIN No. INE03QK01018
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html